Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 14/20 | 0.53 |
| ▸ | MC3R | P41968 | 6/20 | 0.49 |
| ▸ | TSLP | Q969D9 | 6/20 | 0.48 |
| ▸ | MC5R | P33032 | 5/20 | 0.47 |
| ▸ | MC1R | Q01726 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20642598 | 0.97 | MC4R (0.56) | MC4RMC3RTSLPMC5RMC1R | |
| SCHEMBL20642708 | 0.95 | MC4R (0.53) | MC4RMC3RTSLPMC5RMC1R | |
| SCHEMBL20642706 | 0.95 | MC4R (0.53) | MC4RMC3RTSLPMC5RMC1R | |
| SCHEMBL21173584 | 0.95 | MC4R (0.52) | MC4RMC3RMC5RMC1R | |
| SCHEMBL20642750 | 0.92 | MC4R (0.53) | MC4RMC3RTSLPMC5RMC1R | |
| SCHEMBL20642749 | 0.92 | MC4R (0.52) | MC4RMC3RTSLPMC5RMC1R | |
| SCHEMBL20642744 | 0.92 | MC4R (0.50) | MC4RMC3RTSLPMC5RMC1R | |
| SCHEMBL20642815 | 0.91 | MC4R (0.53) | MC4RMC3RMC5RMC1R | |
| SCHEMBL20642775 | 0.90 | MC4R (0.54) | MC4RMC3RMC5RMC1R | |
| SCHEMBL20642593 | 0.90 | MC4R (0.54) | MC4RMC3RMC5RMC1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10179804-B2 | Melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2019-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10179804-B2 | Melanocortin receptor-specific peptides | MC1R, MC3R, MC5R | MC4R 4/4885MC3R 2/4885TSLP 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.